Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, and other chronic cough indications, and for the treatment of prurigo nodularis. Haduvio is an oral extended-release formulation of nalbuphine.
Quick Stats
Jun 23, 202661.7
AI Score
BUY0.64
Volume Ratio
Aug 06, 2026
Next Earnings
17
+ve Days (30d)
12
-ve Days (30d)
TRVI Stock Summary
Last updated Jun 23, 2026
TRVI is currently trading at $17.96, positioned above its 200-day moving average of $11.93, indicating a long-term uptrend. The stock has a 52-week range of $5.41 to $18.11.
Technical Analysis: The 50-day moving average stands at $14.45, which is below the current price, signaling bullish near-term momentum. The RSI (Relative Strength Index) reads 78.501, suggesting the stock is in overbought territory (bullish but caution advised).
Money Flow Indicators: The Chaikin Money Flow (20-day) is 0.144, which is positive, indicating accumulation by institutional investors. Our AI-powered investment score rates TRVI at 61.7/100 with a BUY recommendation.
TRVI (Trevi Therapeutics, Inc. Common Stock) Indicators
Last updated Jun 23, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 78.501 |
| CMF (20) | 0.144 |
| ROC (10) | 32.963 |
| ADX (14) | 31.071 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | 0.847 |
| AROONOSC (14) | 57.143 |
| WILLAMS %R (14) | -3.259 |
| MFI (14) | 87.103 |
TRVI Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
TRVI Price vs Max Options Open Interest
TRVI Max Change In Options Open Interest
TRVI Options - Sort by Max open Interest (near term)
23rd June 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
TRVI Daily Out of Money Options - Sort by Max open Interest (near term)
23rd June 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
TRVI Daily In the Money Options - Sort by Max open Interest (near term)
23rd June 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
TRVI Most Active Options by Volume(near term)
23rd June 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Trevi Therapeutics, Inc. Common Stock is above both 50 Day and 200 Day SMA which is considered Bullish.
TRVI Moving Averages Analysis
Trevi Therapeutics, Inc. Common Stock has been above 50 day sma 1 times in last 30 days. Last time it was above 50 day sma was on Jun 23, 2026
Trevi Therapeutics, Inc. Common Stock has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Jun 23, 2026
TRVI (Trevi Therapeutics, Inc. Common Stock) Simple Moving Averages
Moving Averages are last updated Jun 23, 2026
| Days | MA |
|---|---|
| 10 | 15.4 |
| 20 | 14.65 |
| 30 | 14.54 |
| 50 | 14.45 |
| 100 | 12.97 |
| 200 | 11.93 |
TRVI Fundamental Analysis
| P/E (Forward) | 0 |
| P/E (Trailing) | -- |
| Market Cap ($) | 2.4 billion |
| Earnings/Share ($) | -0.32 |
| Net Proft Margin (%) | 0 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -0.4689 |
| EPS Estimate Next Year ($) | -0.5578 |
| WallStreet Target Price ($) | 23.9 |
| Most Recent Quarter |